Kohler raises the bar on toilet flushing platforms with the launch of its new Revolution 360 swirl flush technology. The brands extensive experience in the toilet industry supports its understanding that critical drivers of owner satisfaction are toilet cleanliness and flush performance – both addressed in the new platform.
Revolution 360 is Kohler’s most complete flush ever developed and is powered by the brand’s widely popular AquaPiston canister technology which allows water to flow out of the tank at 360 degrees, increasing the power and effectiveness of the flush. Once out of the tank the water flows into the bowl from a single, powerful port and swirls throughout the bowl. Utilizing this swirling motion, Revolution 360 keeps the bowl cleaner, longer than a conventional flush. Kohler’s team of engineers engaged experiment and Computational Fluid Dynamics methods to study, improve and perfect even the smallest details to ensure complete rinsing of the entire bowl surface.
To view the multimedia release go to:
https://www.multivu.com/players/English/8176751-kohler-revolution-360-toilet-flushing-platform/
Federally funded research that provides a deep understanding of cancer is spurring advances against many types of the disease. With a strong bipartisan commitment from Congress to keep investment in biomedical research a national priority, we can accelerate our pace of progress and save more lives from cancer, according to the seventh annual American Association for Cancer Research (AACR) Cancer Progress Report, released today.
Basic research in the fields of immunology and cancer genetics has recently been harnessed to develop two new forms of cancer treatment: immunotherapy and precision medicine. As detailed in the report, the utility of these treatments is expanding rapidly. In May 2017, the U.S. Food and Drug Administration (FDA) heralded a new dawn for precision medicine when it approved the immunotherapeutic pembrolizumab (Keytruda) for treating patients with any solid tumor harboring specific genetic characteristics. This is the first anticancer therapeutic approved based on cancer biomarkers rather than the location in the body where the cancer originated.
To view the multimedia release go to:
https://www.multivu.com/players/English/8155051-aacr-cancer-progress-report-2017/
In an effort to improve outcomes for patients with some of the deadliest childhood cancers, St. Jude Children’s Research Hospital scientists have created the world’s largest collection of pediatric solid tumor samples, drug-sensitivity data and related information and have made the resource available at no charge to the global scientific community.
St. Jude and the Howard Hughes Medical Institute collaborated to create the resource, known as the Childhood Solid Tumor Network. The work is reported today as an advance online publication in the scientific journal Nature.
“Survival rates for children with recurrent solid tumors have not improved significantly in more than 20 years and remain below 30 percent,” said corresponding author Michael Dyer, Ph.D., chair of the St. Jude Department of Developmental Neurobiology and a Howard Hughes Medical Institute investigator. “This research will change that by promoting scientific collaboration to leverage the efforts of researchers worldwide to advance understanding and ultimately treatment of pediatric solid tumors.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8121952-st-jude-childrens-childhood-solid-tumor-network/
Bayer and National 4-H Council amplified their commitment to the future of our rapidly expanding global population by launching a new effort to grow the pipeline of tomorrow’s innovators, starting now. The two organizations announced today a nationwide collaboration, Science Matters, which will address the need for an enhanced STEM (science, technology, engineering and math) workforce by planting a love of scientific exploration in thousands of youth in urban and rural areas across the country.
Science Matters will leverage Bayer’s more than 150 years of scientific breakthroughs and 4-H’s century of hands-on learning to equip more than 25,000 youth with tools and support they need to deepen their understanding of science.
To view the multimedia release go to:
https://www.multivu.com/players/English/77126512-bayer-4-h-launch-science-matters/
23andMe, working in collaboration with the Milken Institute and Lundbeck, today announced that they have commenced enrollment for a first-of-its kind genetic study designed to gain understanding of the underlying biology of major depressive and bipolar disorders. This study will combine cognitive assessments with genetic data and survey responses to assess how genes influence brain processes – such as attention, decision-making and visual perception – in individuals who live with these serious mental health conditions.
“We know genetics play a role in the development of depression and bipolar, however there is a long pathway from our genes to the manifestation of complex diseases like these,” said Emily Drabant Conley, PhD., Vice President of Business Development at 23andMe. “We need to look at these conditions in a more comprehensive way to advance our understanding. By studying cognitive function alongside genetics and other environmental variables on a massive scale, we hope to take a significant step forward in the study of depression and bipolar.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8150951-23andme-genetic-study-depression-bipolar-disorders/
Texas Instruments (TI) today launched STEM Behind Cool Careers, a series of calculator activities and videos designed to introduce middle and high school students to unexpected science, technology, engineering and math (STEM) careers. The fun, free activities are designed for the TI-Nspire™ CX and TI-84 Plus CE graphing calculators to show students how a solid understanding of STEM subjects is vital for any career, even careers students least expect.
To view the multimedia release go to:
https://www.multivu.com/players/English/7746258-ti-john-urschel-stem-careers/
More than four in 10 workers (42 percent) in a new survey from global staffing firm Robert Half said they’re likely to look for a new job within the next year. For respondents ages 18 to 34, the number likely to seek new employment in the next 12 months jumps to 68 percent.
Part of the retention challenge for executives is understanding why a good employee might want to leave. Inadequate salary and benefits is the top reason workers said they would quit. However, CFOs reported the number-one reason they think good employees would resign is limited growth potential.
To view the multimedia release go to:
https://www.multivu.com/players/English/7764055-robert-half-retention-survey-results/
WebMD and Scripps Translational Science Institute (STSI) today announced a new investigative study designed to improve researchers’ and health care professionals’ understanding of what contributes to healthy pregnancies and positive pregnancy outcomes. The Healthy Pregnancy Study will use WebMD’s newly redesigned and enhanced Pregnancy app for iPhone. Incorporation of the Apple ResearchKit software framework will enable survey participants to eConsent, easily and anonymously answer questions, and share connected device data about their pregnancies with researchers for analysis.
“Pregnant women are one of the least studied populations in medical research,” said Dr. Eric Topol, director of STSI and editor-in-chief of Medscape. “The results of our Healthy Pregnancy Study -- on the foundation of an exceptionally popular smartphone app -- will ultimately provide expectant mothers, researchers, and health care professionals with new medical insights to avoid complications during pregnancy.”
To view the multimedia release go to:
https://www.multivu.com/players/English/7579757-webmd-stsi-healthy-pregnancy-study-app/
Today on Rare Disease Day, My Life, Our Future, a national program founded by leaders in the bleeding disorder community, including Bloodworks Northwest, the American Thrombosis and Hemostasis Network, the National Hemophilia Foundation and Bioverativ Inc., opened the largest research repository of its kind in the world to scientists. The My Life, Our Future Research Repository is a collection of genetic data and blood samples that are linked to phenotypic data from more than 5,000 people in the U.S. with hemophilia, a rare disorder that impairs the ability of one’s blood to clot. The My Life, Our Future Research Repository will allow researchers to advance the scientific understanding of the disorder, including genetic differences that affect bleeding severity and reaction to certain treatments.
To view the multimedia release go to:
https://www.multivu.com/players/English/8046151-national-hemophilia-foundation-my-life-our-future/
Imagine trying to make a decision with only half the information. Today, nearly all organizations across the public and private sectors rely on data to make better decisions about everything from employee salaries to new legislation. Data provides decision makers insight into what the baseline is, where collective needs are, and where resources should be allocated. But half our world’s population—women—are underrepresented and many times completely unrepresented in these datasets.
Inaccurate data often results from gender bias in the design of surveys or questionnaires, or from someone other than the woman or girl responding to a survey on her behalf. Misrepresented or incomplete gender data collection yields results that misses the mark on understanding women’s needs or their economic and social contributions. Policies and initiatives around healthcare, education, economic opportunity and more are built based on what’s available—gender-biased data—and fail to fairly serve women and girls. How can we close the gender data gap and pursue the global ambition towards gender equality and a fuller understanding of the whole population?
To view the multimedia release go to:
http://www.multivu.com/players/English/7889731-bloomberg-western-digital-bgovdata/
LUNGevity, the nation’s leading lung cancer-focused nonprofit organization today launched a new mobile application designed to make understanding and living with lung cancer less daunting and considerably more manageable. The new Lung Cancer Navigator mobile app provides lung cancer patients with access to the latest medical and treatment information related to their specific lung cancer diagnosis, and serves as a convenient hub for organizing customized care and support networks, asking questions, describing and tracking symptoms, and managing multiple medications.
To view the multimedia release go to:
http://www.multivu.com/players/English/7865551-lungevity-lung-cancer-navigator-app/
Ever since Donna and John met at work three decades ago, they've had the kind of smooth, comfortable relationship that comes when attraction is accompanied by compatible interests as well as strengths and weaknesses that balance each other. They pictured their senior years as an extension of what Donna Dean calls “this nice, easy life. We didn't see the calamity that was coming.”
Brookdale Senior Living, the nation's largest dementia care provider, has created new resources for care partners as part of National Alzheimer's Awareness Month in November. The candid discussion of many of the disease's most difficult challenges includes an up-close look at Donna's and John’s lives since he developed dementia.
To view the multimedia release go to:
http://www.multivu.com/players/English/7722131-brookdale-alzheimers-awareness/
